(Q54599230)

1 June 2018

title

High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. (English)

1 reference

1 June 2018

0 references

Yasuo Miyoshi

1

1 reference

1 June 2018

Satoshi Nakayama

2

1 reference

1 June 2018

Yasuhiro Torikoshi

3

1 reference

1 June 2018

Satoshi Tanaka

4

1 reference

1 June 2018

Hideki Ishihara

5

1 reference

1 June 2018

Tetsuya Taguchi

6

1 reference

1 June 2018

Yasuhiro Tamaki

7

1 reference

1 June 2018

Shinzaburo Noguchi

8

1 reference

1 June 2018

publication date

1 June 2006

1 reference

1 June 2018

published in

Cancer Science

1 reference

1 June 2018

volume

97

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

523-529

1 reference

1 June 2018

Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

The ubiquitin-proteasome pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Expression and functional analysis of Uch-L3 during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

A new cancer diagnostic system based on a CDK profiling technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

Incidence, risk factors and prevention of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00202.X

10.1111/J.1349-7006.2006.00202.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

16734731

1 reference

1 June 2018